x
Turning science into breakthroughs
Ancora Innovation empowers Vanderbilt scientists with the capital and infrastructure to execute novel and potentially transformative research projects.
On April 6, 2018, Vanderbilt University and Deerfield Management announced the launch of Ancora Innovation, a collaboration focused on the union of Vanderbilt’s innovative life science discovery efforts and Deerfield’s commitment to accelerating state-of-the-art drug development.
Deerfield will fund Ancora Innovation with up to $65 million to pursue novel therapeutics and will provide additional capital to fund successful start-up companies that spin out of Ancora.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
Vanderbilt University researchers are at the forefront of discovery, innovation, scholarship, and creative expression. Our mission is to promote Vanderbilt’s distinctive research culture, which aspires to improve the human condition.
Timeline for Proposal Submissions
Proposal Sourcing
Principal Investigators are invited to submit proposals.
Scientific Review
Your proposal will be reviewed by members of our scientific team.
Full Proposal
If your idea is selected for further evaluation, you will be invited to submit a full proposal.
Investment Evaluated
Your proposal will be carefully evaluated for funding by Deerfield’s investment team.
For more information on proposal submissions, please reach out to Margaret Read, Ancora Innovation Alliance Manager, at margaret.a.read@vanderbilt.edu.
